Ekso Bionics (NASDAQ:EKSO – Get Free Report) released its earnings results on Monday. The company reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.02), Yahoo Finance reports. Ekso Bionics had a negative return on equity of 95.36% and a negative net margin of 79.48%. The business had revenue of $4.95 million during the quarter, compared to the consensus estimate of $5.34 million. During the same quarter in the previous year, the firm earned ($0.31) earnings per share.
Ekso Bionics Stock Down 30.6 %
EKSO traded down $0.46 on Tuesday, reaching $1.03. 444,034 shares of the company traded hands, compared to its average volume of 131,178. Ekso Bionics has a 52-week low of $0.62 and a 52-week high of $3.13. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.81 and a quick ratio of 2.11. The company has a market cap of $18.72 million, a price-to-earnings ratio of -1.13 and a beta of 1.51. The stock’s 50 day moving average price is $1.16 and its 200-day moving average price is $1.47.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on EKSO shares. HC Wainwright reaffirmed a “buy” rating and issued a $10.00 price target on shares of Ekso Bionics in a report on Tuesday. StockNews.com assumed coverage on shares of Ekso Bionics in a research note on Tuesday. They set a “hold” rating for the company. Finally, Lake Street Capital started coverage on shares of Ekso Bionics in a research note on Monday, June 24th. They issued a “buy” rating and a $2.50 price objective for the company.
About Ekso Bionics
Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
Featured Stories
- Five stocks we like better than Ekso Bionics
- What is a Stock Market Index and How Do You Use Them?
- Pharma Stock Cuts Earnings Outlook: Still a Buying Opportunity
- Following Congress Stock Trades
- This Semiconductor Stock Is ON Track for a New High
- What is the NASDAQ Stock Exchange?
- Why SoFi Stock is an Unmissable Growth Opportunity
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.
